Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A‐I is protective for the incidence of primary acute myocardial infarction in middle‐aged males. An incident case–control study from Sweden

• Published in: Journal of Internal Medicine
• Main Authors: Dahlén, Weinehall, Stenlund, Jansson, Hallmans, Huhtasaari, Wall
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wiley 1998
• Subjects: Luleå; Northern Sweden
• Online Access: http://dx.doi.org/10.1046/j.1365-2796.1998.00422.x; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2796.1998.00422.x; https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2796.1998.00422.x; https://onlinelibrary.wiley.com/doi/full-xml/10.1046/j.1365-2796.1998.00422.x

Abstract. Dahlén GH, Weinehall L, Stenlund H, Jansson J‐H, Hallmans G, Huhtasaari F, Wall S (Umeå University, Umeå; Skellefteå County Hospital; and Luleå‐Boden County Hospital, Sweden). Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A‐I is protective for the incidence o...